Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 5:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2857–2880 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Gestational Diabetes
Interventions: Ankle weights (2.5 pounds [1.1 kg]/ankle), Control; Behavioral
Lead sponsor: Sarah Keim; Other
Eligibility: 18 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Femoral Fracture, Fragility Fracture, Muscle Atrophy
Interventions: Essential Amino Acid Supplementation; Combination Product
Lead sponsor: Michael C Willey; Other
Eligibility: 65 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Iowa City, Iowa • Eugene, Oregon

Conditions: Total Hip Arthroplasty, Total Knee Arthroplasty
Interventions: SurgX Antimicrobial Wound Gel, Standard of Care; Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 3
States / cities: Manhasset, New York • New Hyde Park, New York • New York, New York

Conditions: Iron Deficiency Anemia Treatment, Iron-deficiency, Iron Deficiency Anemia Due to Blood Loss, Iron Deficiency Anemia
Interventions: Packed red blood cells, Intravenous drug; Biological · Drug
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 18 Years to 80 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Headache Disorders, Primary, Pain Management, Emergency Department
Interventions: Paracervical injection, prochlorperazine and diphenhydramine.(Standard Treatment); Drug
Lead sponsor: Christian Fromm, MD; Other
Eligibility: 18 Years to 64 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Excision of Kidney
Interventions: Surgeon's 'standard of care' stapler, Ethicon Powered Vascular Stapler; Device
Lead sponsor: Ethicon Endo-Surgery; Industry
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pancreatic Carcinoma
Interventions: Pancreaticoduodenectomy; Procedure
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Overactive Bladder, Overactive Detrusor, Overactive Bladder Syndrome, Overactivity; Behavior, Urge Incontinence
Interventions: Bicarbonate protocol, Standard protocol; Drug
Lead sponsor: Boston Urogynecology Associates; Other
Eligibility: 18 Years and older · Female only
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Pediatrics, Neurologic Dysfunction, Vibration Therapy
Interventions: ViBandz; Device
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 6 Months to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Pulmonary Disease, Chronic Obstructive, Heart Failure
Interventions: Pharmacist Counseling; Procedure
Lead sponsor: Wilkes University; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Scranton, Pennsylvania

Conditions: Rotator Cuff Tear
Interventions: BPC-157, Sham (No Treatment); Drug · Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Heel Pressure Ulceration Prevention Strategies
Interventions: Pillow Condition 1, Pillow Condition 2, Heel Foam Pillow, Offloading Device A, Offloading Device B, Offloading Device C; Other · Device
Lead sponsor: DeRoyal Industries, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Nasopharyngeal Carcinoma
Interventions: Spartalizumab, Investigator choice of chemotherapy; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 4
States / cities: Marietta, Georgia • Detroit, Michigan • New York, New York + 1 more

Conditions: Breast Neoplasm Female
Interventions: Oculus Go Virtual Reality Goggles; Device
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Nicotine Dependance, Serious Mental Illness, Smoking (Tobacco) Addiction, Tobacco Cessation, Community Health Workers, Cardiovascular (CV) Risk, Tobacco Use Disorder
Interventions: Integrated CHW Support intervention, Enhanced usual care (EUC); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 937 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infections, Crack Cocaine Use, Risky Sexual Behavior
Interventions: Prevention Care Advocate; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 413 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 2
States / cities: Miami, Florida • Atlanta, Georgia

Conditions: Pancreatic Cancer
Interventions: LY2495655, Placebo, Standard of Care Chemotherapy; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Dallas, Texas • The Woodlands, Texas + 2 more

Conditions: High Cardiovascular Risk, Hypertension
Interventions: Zilebesiran, Placebo; Drug
Lead sponsor: Alnylam Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 375 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 139
States / cities: Alexander City, Alabama • Daphne, Alabama • Foley, Alabama + 115 more

Conditions: Alzheimer's Disease
Interventions: AGN-242071, Placebo, Donepezil, Memantine; Drug
Lead sponsor: Allergan; Industry
Eligibility: 55 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 6
States / cities: Costa Mesa, California • Irvine, California • Lemon Grove, California + 2 more

Conditions: Inappropriate Prescribing
Interventions: Prescribing Feedback; Behavioral
Lead sponsor: Yale University; Other
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Corneal Ulcer, Infectious Keratitis, Bacterial Ulcer, Fungal Ulcer
Interventions: Corneal Cross-linking, Anti Fungal Drug; Procedure · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Vaginal Delivery, Pelvic Organ Prolapse
Interventions: Materna Prep Device, Standard of Care (SOC); Device · Other
Lead sponsor: Materna Medical; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 22
States / cities: Birmingham, Alabama • Greenbrae, California • Los Angeles, California + 18 more

Conditions: Chronic Kidney Disease
Interventions: Culinary Medicine Nutrition and Cooking Education; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Hip Fracture
Interventions: UFNB (Ultrasound guided femoral nerve block), UFIB (Ultrasound Guided Fascia Iliaca Compartment Block), IVMS (IV Morphine); Procedure · Drug
Lead sponsor: Antonios Likourezos; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Brooklyn, New York

Search by objective public record fields.

Physical Activity Intervention for Gestational Diabetes

Essential Amino Acid Supplementation for Femoral Fragility Fractures

Clinical Evaluation of the Next Science SurgX Antimicrobial Wound Gel Impact on Surgical Site Complications

IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department

Paracervical Injection for Headache in the Emergency Department

An Evaluation of a Powered Vascular Stapler in Laparoscopic Nephrectomies and Nephroureterectomies

Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer

Minimizing Pain During Office Intradetrussor Botox Injection

ViBandz Feasibility Study

Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model

Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery

Evaluation of Heel Offloading Devices for Reducing Heel Contact Pressures in Healthy Volunteers

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

VR Ultrasound Guided Breast Localization

Evaluation of Community Health Worker Support to Help People With Serious Mental Illness to Quit Smoking

Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users

A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

A Trial to Reduce Inappropriate Prescribing to Older Adults Visiting the Emergency Department

Cross-linking for Corneal Ulcers Treatment Trial

EASE: The Materna Prep Pivotal Study

Food As Medicine to Reduce CKD Burden in Health Disparity Populations

Ultrasound Guided Pain Control Versus Standard Treatment in Emergency Department HIP Fracture Patients